Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Cutaneous and Ocular Toxicology|December 7, 2007
In vitro approaches to the identification and characterization of skin sensitizersDavid Basketter, Gavin MaxwellAlternatives to Laboratory Animals : ATLA|November 26, 2008
Application of a systems biology approach to skin allergy risk assessmentGavin Maxwell, Cameron MackayContact Dermatitis|December 8, 2018
Skin sensitization: Uncertainties, challenges, and opportunities for improved risk assessmentNicola Gilmour, Ian Kimber, Jason Williams, et al.ALTEX|November 1, 2013
From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessmentCameron MacKay, Michael Davies, Vicki Summerfield, et al.Protein Expression and Purification|January 29, 2002
Bacterial expression and purification of recombinant bovine Fab fragmentsPhilippa M O'Brien, Gavin Maxwell, M Saveria CampoAlternatives to Laboratory Animals : ATLA|August 31, 2021
Upholding the EU's Commitment to 'Animal Testing as a Last Resort' Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety ScienceJulia Fentem, Ian Malcomber, Gavin Maxwell, et al.International Immunology|December 20, 2005
Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cellsCornelia Mundt, Steve Licence, Gavin Maxwell, et al.Immunology|September 10, 2008
Toll-like receptor ligand activation of murine bone marrow-derived dendritic cellsRebecca J Dearman, Marie Cumberbatch, Gavin Maxwell, et al.Contact Dermatitis|May 5, 2016
T lymphocyte dynamics in methylisothiazolinone-allergic patientsAmy Popple, Jason Williams, Gavin Maxwell, et al.Journal of Immunotoxicology|February 7, 2015
The lymphocyte transformation test in allergic contact dermatitis: New opportunitiesAmy Popple, Jason Williams, Gavin Maxwell, et al.Pageof 5